Welcome to Pangaea insights

Our collective intelligence provides an unrivalled breadth and depth of knowledge.

Pangaea’s ongoing relationships with key industry stakeholders facilitate continuous updates and dissemination of relevant market intelligence. Check back often for new posts!

The Pangaea Group Announcement

January 1, 2021
Two new appointments for The Pangaea Group effective January 1, 2021.

Pangaea Express: Health Canada responds to U.S. Drug Importation

December 1, 2020
Health Canada (HC) has issued an Interim Order (IO) to safeguard Canada’s drug supply from diversion.

Pangaea Express: The Final PMRPB Guidelines

October 23, 2020
The final PMPRB Guidelines have been published along with an "Overview of Final Changes" that differ from the June 2020 draft Guidelines.

Pangaea Express: Interim Order to expedite approval for COVID-19 medicines

September 18, 2020
On September 16, 2020, the Feds issued an Interim Order Respecting the Importation, Sale and Advertising of Drugs for Use in Relation to COVID-19 that allows for the Minister of Health to expedite review of COVID-19 drugs in Canada. There are three routes.

Navigating while innovating: Considerations for launching in a risk-averse environment

August 21, 2020
Sometimes the new normal is simply dealing with a new level of systematic complexity that arises as the health economy and population grows, and we grapple with an ever-expanding landscape of health system needs that are as complex as they are diverse.

Pangaea Express: Impact of the recent Federal Court decision on PMPRB Guidelines

July 9, 2020
On July 8, the PMPRB updated its website to include its views on the recent Federal Court decision pertaining to the amendments to the Patented Medicines Regulations and their impact on the Guidelines.

Join our team

June 22, 2020
Join our team: Pangaea is seeking a part-time / independent consultant to support our trade team as a Trade Manager.

A Year In Review for R2D2

June 3, 2020
Overall, there are 14 projects under the R2D2 initiative that can be bucketed into four categories. Read more.

Pangaea Express: Vendor Credentialing and COVID-19

June 2, 2020
It will be critical for companies to be aware of external policies to find the right balance of criteria for re-entry into clinics & hospitals to ensure a safe and productive interaction for the benefit of Canadian patients.

Pangaea Express: Amendments to Pricing Regulations delayed to January 1, 2021

May 29, 2020
Pangaea confirms the amendments to the Patented Medicines Regulations to take effect July 1, 2020, will be implemented January 1, 2021.
← Prev
Page 3 of 10
Next →